98 related articles for article (PubMed ID: 2925152)
1. Urinary dopamine, noradrenaline and adrenaline in type 2 diabetic patients with and without nephropathy.
Murabayashi S; Baba T; Tomiyama T; Takebe K
Horm Metab Res; 1989 Jan; 21(1):27-32. PubMed ID: 2925152
[TBL] [Abstract][Full Text] [Related]
2. Decreased urinary excretion of dopamine and sodium in diabetic children with incipient nephropathy.
Madácsy L; Sulyok E; Klujber L; Vámosi I; Barkai L; Baranyai Z
Padiatr Padol; 1991; 26(6):253-6. PubMed ID: 1792093
[TBL] [Abstract][Full Text] [Related]
3. Low urinary dopamine excretion associated to low sodium excretion in normotensive Piaroa Amazonian ethnia compared to urban subjects.
Romero-Vecchione E; Vásquez J; Lema G; Guerrero H; Rosa F; Bermúdez M
Invest Clin; 1995 Jun; 36(2):61-71. PubMed ID: 7548301
[TBL] [Abstract][Full Text] [Related]
4. Effect of red wine on urinary protein, 8-hydroxydeoxyguanosine, and liver-type fatty acid-binding protein excretion in patients with diabetic nephropathy.
Nakamura T; Fujiwara N; Sugaya T; Ueda Y; Koide H
Metabolism; 2009 Aug; 58(8):1185-90. PubMed ID: 19481229
[TBL] [Abstract][Full Text] [Related]
5. Effects of captopril on urinary excretion of albumin and prostaglandins in patients with diabetic nephropathy.
Tajiri Y; Umeda F; Inoguchi T; Kunisaki M; Nawata H; Ninomiya H; Asano T
Diabetes Res; 1990 Mar; 13(3):145-50. PubMed ID: 2091882
[TBL] [Abstract][Full Text] [Related]
6. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.
Navarro JF; Mora C; Muros M; García J
Nephrol Dial Transplant; 2006 Dec; 21(12):3428-34. PubMed ID: 16935891
[TBL] [Abstract][Full Text] [Related]
7. Familial factors in diabetic nephropathy: an offspring study.
Agius E; Attard G; Shakespeare L; Clark P; Vidya MA; Hattersley AT; Fava S
Diabet Med; 2006 Mar; 23(3):331-4. PubMed ID: 16492220
[TBL] [Abstract][Full Text] [Related]
8. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
[TBL] [Abstract][Full Text] [Related]
9. [Regulation of natriuresis in diabetic nephropathy].
Późniak J
Ann Acad Med Stetin; 2000; 46():241-52. PubMed ID: 11712308
[TBL] [Abstract][Full Text] [Related]
10. Excretion of catecholamines and metabolites in response to increased dietary phosphate intake.
Berndt TJ; MacDonald A; Walikonis R; Chinnow S; Dousa TP; Tyce GM; Knox FG
J Lab Clin Med; 1993 Jul; 122(1):80-4. PubMed ID: 8320494
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
Wang QY; Chen FQ
Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
[TBL] [Abstract][Full Text] [Related]
12. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
[TBL] [Abstract][Full Text] [Related]
13. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients.
Wirta OR; Pasternack AI; Mustonen JT; Koivula TA; Harmoinen A
Nephrol Dial Transplant; 1996 Mar; 11(3):449-56. PubMed ID: 8671814
[TBL] [Abstract][Full Text] [Related]
14. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
Ha SW; Kim HJ; Bae JS; Jeong GH; Chung SC; Kim JG; Park SH; Kim YL; Kam S; Kim IS; Kim BW
Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
[TBL] [Abstract][Full Text] [Related]
15. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
Cha DR; Kim IS; Kang YS; Han SY; Han KH; Shin C; Ji YH; Kim NH
Diabet Med; 2005 Jan; 22(1):14-20. PubMed ID: 15606685
[TBL] [Abstract][Full Text] [Related]
16. [Increased urinary iron excretion rate in patients with non-insulin dependent diabetes mellitus].
Nishiya K; Takamatsu K; Yoshimoto Y; Ikeda Y; Ito H; Hashimoto K
Rinsho Byori; 1996 Dec; 44(12):1201-2. PubMed ID: 8990941
[TBL] [Abstract][Full Text] [Related]
17. Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients with Type 2 diabetic nephropathy.
Higurashi M; Ohya Y; Joh K; Muraguchi M; Nishimura M; Terawaki H; Yagui K; Hashimoto N; Saito Y; Yamada K
J Diabetes Complications; 2009; 23(3):178-84. PubMed ID: 18413205
[TBL] [Abstract][Full Text] [Related]
18. Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression.
Popławska-Kita A; Mierzejewska-Iwanowska B; Szelachowska M; Siewko K; Nikołajuk A; Kinalska I; Górska M
Diabetes Metab Res Rev; 2008; 24(4):310-7. PubMed ID: 18273859
[TBL] [Abstract][Full Text] [Related]
19. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.
Mocan Z; Erem C; Yildirim M; Telatar M; Değer O
Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
Katavetin P; Eiam-Ong S; Suwanwalaikorn S
J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
